OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +140.0% | 3,011 | +325.9% | 0.00% | – |
| Q4 2021 | $5,000 | -99.4% | 707 | -99.1% | 0.00% | -100.0% |
| Q3 2021 | $825,000 | -29.7% | 82,500 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $1,174,000 | -13.8% | 82,774 | -0.2% | 0.00% | -33.3% |
| Q1 2021 | $1,362,000 | -20.7% | 82,972 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,718,000 | +42850.0% | 82,972 | +11753.1% | 0.00% | – |
| Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 700 | -26.3% | 0.00% | – |
| Q3 2016 | $7,000 | +133.3% | 950 | +35.7% | 0.00% | – |
| Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |